The level of adenosine deaminase in the serum of patients who have positive Entamoeba coli

dc.authoridKıran, Tugba Raika/0000-0002-3724-0249
dc.authoridÇOLAK, CEMİL/0000-0001-5406-098X
dc.authoridKIRAN, TUGBA RAIKA/0000-0002-3724-0249
dc.authoridözer, ali/0000-0002-7144-4915
dc.authorwosidKıran, Tugba Raika/HFZ-9643-2022
dc.authorwosidÇOLAK, CEMİL/ABI-3261-2020
dc.authorwosidKIRAN, TUGBA RAIKA/AAA-8224-2021
dc.authorwosidözer, ali/ABI-2209-2020
dc.contributor.authorKiran, Tugba Raika
dc.contributor.authorKaraman, Ulku
dc.contributor.authorColak, Cemil
dc.contributor.authorOzer, Ali
dc.date.accessioned2024-08-04T20:36:06Z
dc.date.available2024-08-04T20:36:06Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: The entomoeba coli which is an intestinal parasite is known as apatojen. However in some studies it has also been reported that it may be pathogenic. The Adenosine deaminase (ADA) is the key enzyme of purine metabolizm and controls the levels of adenosine and deoxy adenosine in the cell. The researchers have found that ADA is a marker of cellular immunity and the increased ADA serum in different diseases. In the study the comparison of ADA levels between the serums of the patients with detected Entamoeba coli (E. coli) and the control group is purposed. Methods: In this study the levels of ADA in the serums of 40 control groups and 35 patients who have E. coli are measured. When comparing the averages of the patients and control groups, the independent sample T test was also used. The mean age of the group is 37.97 +/- 5.06, 31 (89%) male and 4 (11%) of them are women. The mean age of healthy 40 people is 40.23 +/- 7.01, 31 (77%) males and 9 (23%) of them are women. Results: In the study according to the controls a significant increase is observed in ADA activity of the patient group. Conclusions: The findings seem to support the parasite's pathojen. In the studies which will be planned to determine whether the parasite is pathogenic or not, the detection of ADA values of Entemoeba coli diagnosed patients' before and after treatment will be guiding. In addition, the determination of ADA levels can give information about the immune mechanisms and we also can reach a conclusion that it can support the criterias for diagnosis and treatment of patients with positive Entemoeba coli.en_US
dc.identifier.endpage2111en_US
dc.identifier.issn1840-2291
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-84865453662en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage2108en_US
dc.identifier.urihttps://hdl.handle.net/11616/95785
dc.identifier.volume6en_US
dc.identifier.wosWOS:000308021500035en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherDrunpp-Sarajevoen_US
dc.relation.ispartofHealthmeden_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEntemoeba colien_US
dc.subjectAdenosine deaminaseen_US
dc.subjectIntestinal parasiteen_US
dc.subjectPathogenen_US
dc.titleThe level of adenosine deaminase in the serum of patients who have positive Entamoeba colien_US
dc.typeArticleen_US

Dosyalar